Analysis Suggests Use of RADICAVA IV is Associated with Improved Survival in People with ALS JERSEY CITY, N.J., April 4, 2022 — Mitsubishi Tanabe Pharma America, Inc. (MTPA) today …
Tag:
neurology
-
-
Presentations Include Real-World Data on RADICAVA® (edaravone) and Results from a Global Phase 3 Study of Investigational Oral Edaravone JERSEY CITY, N.J., April 1, 2022 — Mitsubishi Tanabe Pharma America, …